<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01911819</url>
  </required_header>
  <id_info>
    <org_study_id>5130213</org_study_id>
    <nct_id>NCT01911819</nct_id>
  </id_info>
  <brief_title>A Comparison of Bone Formation With Three Different Bone Graft Materials Following Sinus Graft</brief_title>
  <official_title>A Histomorphometric Analysis of Bone Formation With Three Different Bone Graft Materials Following Sinus Augmentation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Luitpold Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare new bone formation following bone graft in sinus
      using three different commercially available bone graft materials. The study hypothesis is
      that there is no difference in new bone formation among three bone graft materials under
      microscope.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this investigation is to compare new bone formation through histomorphometric
      analysis following maxillary sinus augmentation using three different bone graft materials.
      Null Hypothesis is that there is no histomorphometric difference in new bone formation in
      maxillary sinuses augmented using three different materials; anorganic bovine bone graft
      (Bio-Oss), anorganic equine bone graft (Equimatrix) and mineralized bone allograft (OSSIF-i
      sem). Patients who require sinus augmentation prior to implant placement will be selected to
      participate in this study. All patients will be randomly placed into three groups according
      to bone graft materials that will be used. Group A (Control group,n=10): Maxillary sinus
      augmentation using anorganic bovine bone graft (Bio-Oss), Group B (Test group,n=10):Maxillary
      sinus augmentation using anorganic equine bone graft (Equimatrix), and Group C (Test
      group,n=10):Maxillary sinus augmentation using mineralized bone allograft (OSSIF-i sem). All
      the patients will be treated with the same surgical technique consisting of sinus floor
      augmentation via a lateral approach.After a full-thickness flap reflection to expose the
      lateral wall of the sinus each antrostomy will be outlined with a carbide round bur and sinus
      membranes will be carefully elevated. If a perforation to the sinus membrane occurs, and if
      the perforation is &lt; 5 mm in diameter and is able to be repaired, the surgeon will continue
      the procedure. Any perforation &gt; 5 mm will be excluded from this study. Bone graft materials
      will be placed into the each sinus compartment for the three groups. After 8 months of
      healing, biopsy specimen will be collected from the previous antrostomy sites.
      Histomorphometric measurements of the percentage of vital bone of the area of bone. The
      percentage of non-bone material (allograft or xenograft) and the percentage of connective
      tissue will be also analyzed. Then the primary hypothesis will be analyzed statistically.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Percentage of Vital Bone in a Total Amount of a Bone Specimen</measure>
    <time_frame>24months</time_frame>
    <description>Bone biopsy was taken in a mean of 9.1 months after sinus graft procedure from previous lateral window of maxillary sinus. The bone cores were analyzed though histomorphometric analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Percentage of Non-vital Bone/Residual Bone Graft Material in a Bone.</measure>
    <time_frame>24months</time_frame>
    <description>Bone biopsy was taken in a mean of 9.1 months after sinus graft procedure from previous lateral window of maxillary sinus. The bone cores were analyzed though histomorphometric analysis.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Inadequate Bone Height in Maxillary Posterior Area</condition>
  <arm_group>
    <arm_group_label>Sinus augmentation using Bio-oss</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sinus augmentation using Bio-oss</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sinus augmentation using Equimatrix</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sinus augmentation using Equimatrix</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sinus augmentation using OSSIF-i sem</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sinus augmentation using OSSIF-i sem</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sinus augmentation</intervention_name>
    <arm_group_label>Sinus augmentation using Bio-oss</arm_group_label>
    <arm_group_label>Sinus augmentation using Equimatrix</arm_group_label>
    <arm_group_label>Sinus augmentation using OSSIF-i sem</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Equimatrix</intervention_name>
    <description>Equimatrix cancellous particle size 0.2-1mm approximately 2g (4cc)</description>
    <arm_group_label>Sinus augmentation using Equimatrix</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>OSSIF-i sem</intervention_name>
    <description>OSSIF-i sem Mineralized Cancellous Bone Allograft SP 0.25-1.0mm approximately 2cc x 2</description>
    <arm_group_label>Sinus augmentation using OSSIF-i sem</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bio-oss</intervention_name>
    <description>Bio-oss small granules cancellous 0.25-1mm, approximately 2g (4cc)</description>
    <arm_group_label>Sinus augmentation using Bio-oss</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Over 18 years old who are able to read and sign written consent form.

          2. Patient who has good oral hygiene (Full-mouth plaque score &lt;25%).

          3. Subject would be available for study monitoring.

          4. Patients with missing teeth in the maxillary posterior region who will require sinus
             augmentation f or implant placement. The patients may be partially or completely
             edentulous.

          5. Delayed implant placement approximately 8 months following sinus grafting.

        Exclusion Criteria:

        A medical history that will complicate the outcome of the study such as:

          1. alcohol, drug dependency,

          2. signs or symptoms of maxillary sinus disease,

          3. current smoker,

          4. history of head and neck radiation treatment,

          5. poor health or any other medical, physical or psychological reason that might affect
             the surgical procedure or the subsequent prosthodontic treatment and/or required
             follow-up examinations.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Kan, DDS, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University School of Dentistry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Loma Linda University School of Dentistry</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2013</study_first_submitted>
  <study_first_submitted_qc>July 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2013</study_first_posted>
  <results_first_submitted>August 10, 2017</results_first_submitted>
  <results_first_submitted_qc>November 9, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">December 13, 2017</results_first_posted>
  <last_update_submitted>November 9, 2017</last_update_submitted>
  <last_update_submitted_qc>November 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loma Linda University</investigator_affiliation>
    <investigator_full_name>Joseph Kan, DDS</investigator_full_name>
    <investigator_title>Professor of Restorative Dentistry</investigator_title>
  </responsible_party>
  <keyword>Histomorphometric Analysis</keyword>
  <keyword>New bone Formation</keyword>
  <keyword>Sinus Augmentation</keyword>
  <keyword>Bone Graft Materials</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>The enrolled patients had either unilateral or bilateral maxillary sinus requiring maxillary sinus graft. For patients with bilateral sinus, each maxillary sinus was randomly assigned different treatment groups.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Sinus Augmentation Using Equimatrix</title>
          <description>Sinus augmentation using Equimatrix
Sinus augmentation
Equimatrix: Equimatrix cancellous particle size 0.2-1mm approximately 2.5g (5cc)</description>
        </group>
        <group group_id="P2">
          <title>Sinus Augmentation Using Bio-oss</title>
          <description>Sinus augmentation using Bio-oss
Sinus augmentation
Bio-oss: Bio-oss small granules cancellous 0.25-1mm, approximately 2.5g (5cc)</description>
        </group>
        <group group_id="P3">
          <title>Sinus Augmentation Using OSSIF-i Sem</title>
          <description>Sinus augmentation using OSSIF-i sem
Sinus augmentation
OSSIF-i sem: OSSIF-i sem Mineralized Cancellous Bone Allograft SP 0.25-1.0mm approximately 5cc</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="11">One of 10 sinuses was replaced to another sinus due to infection.</participants>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Either partially or completely edentulous posterior maxilla were included. In event of a bilateral maxillary sinuses, each maxillary sinus was randomly assigned different groups. Therefore, the number of participants overlaps. Two sinuses in Bio-Oss group, 1 sinus in Equimatrix group were removed from the study according to the study protocol.</population>
      <group_list>
        <group group_id="B1">
          <title>Sinus Augmentation Using Bio-oss</title>
          <description>Sinus augmentation using Bio-oss
Sinus augmentation
Bio-oss: Bio-oss small granules cancellous 0.25-1mm, approximately 2.5g (5cc)</description>
        </group>
        <group group_id="B2">
          <title>Sinus Augmentation Using Equimatrix</title>
          <description>Sinus augmentation using Equimatrix
Sinus augmentation
Equimatrix: Equimatrix cancellous particle size 0.2-1mm approximately 2.5g (5cc)</description>
        </group>
        <group group_id="B3">
          <title>Sinus Augmentation Using OSSIF-i Sem</title>
          <description>Sinus augmentation using OSSIF-i sem
Sinus augmentation
OSSIF-i sem: OSSIF-i sem Mineralized Cancellous Bone Allograft SP 0.25-1.0mm approximately 5cc</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="10"/>
            <count group_id="B4" value="21"/>
          </count_list>
        </analyzed>
        <analyzed>
          <units>Maxillary sinus</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="10"/>
            <count group_id="B4" value="28"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>The numbers of analyzed were based on the numbers of maxillary sinuses, therefore, the total number of unique participants is different.</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <units_analyzed>Maxillary sinus</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.9" lower_limit="33" upper_limit="75"/>
                    <measurement group_id="B2" value="65.6" lower_limit="54" upper_limit="72"/>
                    <measurement group_id="B3" value="57.9" lower_limit="29" upper_limit="75"/>
                    <measurement group_id="B4" value="61.5" lower_limit="29" upper_limit="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <class_list>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Percentage of Vital Bone in a Total Amount of a Bone Specimen</title>
        <description>Bone biopsy was taken in a mean of 9.1 months after sinus graft procedure from previous lateral window of maxillary sinus. The bone cores were analyzed though histomorphometric analysis.</description>
        <time_frame>24months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sinus Augmentation Using Bio-oss</title>
            <description>Sinus augmentation using Bio-oss
Sinus augmentation
Bio-oss: Bio-oss small granules cancellous 0.25-1mm, approximately 2.5g (5cc)</description>
          </group>
          <group group_id="O2">
            <title>Sinus Augmentation Using Equimatrix</title>
            <description>Sinus augmentation using Equimatrix
Sinus augmentation
Equimatrix: Equimatrix cancellous particle size 0.2-1mm approximately 2.5g (5cc)</description>
          </group>
          <group group_id="O3">
            <title>Sinus Augmentation Using OSSIF-i Sem</title>
            <description>Sinus augmentation using OSSIF-i sem
Sinus augmentation
OSSIF-i sem: OSSIF-i sem Mineralized Cancellous Bone Allograft SP 0.25-1.0mm approximately 5cc</description>
          </group>
        </group_list>
        <measure>
          <title>The Percentage of Vital Bone in a Total Amount of a Bone Specimen</title>
          <description>Bone biopsy was taken in a mean of 9.1 months after sinus graft procedure from previous lateral window of maxillary sinus. The bone cores were analyzed though histomorphometric analysis.</description>
          <units>percentage of vital bone</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Maxillary sinuses</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Maxillary sinuses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.9" spread="8.9"/>
                    <measurement group_id="O2" value="9.1" spread="5.9"/>
                    <measurement group_id="O3" value="32.0" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Percentage of Non-vital Bone/Residual Bone Graft Material in a Bone.</title>
        <description>Bone biopsy was taken in a mean of 9.1 months after sinus graft procedure from previous lateral window of maxillary sinus. The bone cores were analyzed though histomorphometric analysis.</description>
        <time_frame>24months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sinus Augmentation Using Bio-oss</title>
            <description>Sinus augmentation using Bio-oss
Sinus augmentation
Bio-oss: Bio-oss small granules cancellous 0.25-1mm, approximately 2.5g (5cc)</description>
          </group>
          <group group_id="O2">
            <title>Sinus Augmentation Using Equimatrix</title>
            <description>Sinus augmentation using Equimatrix
Sinus augmentation
Equimatrix: Equimatrix cancellous particle size 0.2-1mm approximately 2.5g (5cc)</description>
          </group>
          <group group_id="O3">
            <title>Sinus Augmentation Using OSSIF-i Sem</title>
            <description>Sinus augmentation using OSSIF-i sem
Sinus augmentation
OSSIF-i sem: OSSIF-i sem Mineralized Cancellous Bone Allograft SP 0.25-1.0mm approximately 5cc</description>
          </group>
        </group_list>
        <measure>
          <title>The Percentage of Non-vital Bone/Residual Bone Graft Material in a Bone.</title>
          <description>Bone biopsy was taken in a mean of 9.1 months after sinus graft procedure from previous lateral window of maxillary sinus. The bone cores were analyzed though histomorphometric analysis.</description>
          <units>percentage of residual bone materials</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Maxillary Sinuses</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Maxillary Sinuses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.3" spread="12.1"/>
                    <measurement group_id="O2" value="38.9" spread="5.3"/>
                    <measurement group_id="O3" value="5.5" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event was monitored up to 2 weeks.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Sinus Augmentation Using Bio-oss</title>
          <description>Sinus augmentation using Bio-oss
Sinus augmentation
Bio-oss: Bio-oss small granules cancellous 0.25-1mm, approximately 2.5g (5cc)</description>
        </group>
        <group group_id="E2">
          <title>Sinus Augmentation Using Equimatrix</title>
          <description>Sinus augmentation using Equimatrix
Sinus augmentation
Equimatrix: Equimatrix cancellous particle size 0.2-1mm approximately 2.5g (5cc)</description>
        </group>
        <group group_id="E3">
          <title>Sinus Augmentation Using OSSIF-i Sem</title>
          <description>Sinus augmentation using OSSIF-i sem
Sinus augmentation
OSSIF-i sem: OSSIF-i sem Mineralized Cancellous Bone Allograft SP 0.25-1.0mm approximately 5cc</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Maxillary sinus infection</sub_title>
                <description>An acute sinus infection was noted in one sinus in the group of sinus augmentation using Bio-Oss. The graft materials were removed. maxillary sinus compartment was cleaned, irrigated and the area was sutured after the sinus graft procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Joseph Kan</name_or_title>
      <organization>Loma Linda University</organization>
      <phone>(909) 558-4980</phone>
      <email>jkan@llu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

